Valuation: Dermapharm Holding SE

Market Cap 2.03B 2.34B 1.9B 1.74B 3.28B 223B 3.34B 22.36B 8.76B 111B 8.78B 8.58B 366B P/E 2026 *
15.4x
P/E 2027 * 14x
Enterprise Value 2.82B 3.25B 2.64B 2.42B 4.56B 310B 4.64B 31.08B 12.17B 154B 12.2B 11.93B 509B EV / Sales 2026 *
2.34x
EV / Sales 2027 * 2.13x
Free-Float
10.7%
Yield 2026 *
2.48%
Yield 2027 * 2.74%
1 day-0.12%
1 week+1.74%
1 month-12.67%
3 months-11.54%
6 months+16.81%
Current year+4.19%
1 week 40.65
Extreme 40.65
43.3
1 month 39.95
Extreme 39.95
47.6
Current year 34.3
Extreme 34.3
51.9
1 year 31.7
Extreme 31.7
51.9
3 years 30.15
Extreme 30.15
51.9
5 years 30.15
Extreme 30.15
91.95
10 years 21.58
Extreme 21.575
91.95
Manager TitleAgeSince
Chief Executive Officer 64 01/08/2017
Director of Finance/CFO - 01/11/2022
Investor Relations Contact - 01/12/2018
Director TitleAgeSince
Chairman 70 01/08/2017
Director/Board Member 66 01/08/2017
Director/Board Member 77 01/01/2018
Date Insider Type Main position Quantity % Market Cap.
1/7/26 A Buy 150 0.0003%
1/7/26 A Buy 150 0.0003%
1/7/26 A Buy 2,050 0.0038%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+1.74%+23.49%-4.47% 2.34B
-2.39%-6.24%+47.10%+146.73% 1,024B
-0.76%-3.41%+52.04%+49.73% 618B
-2.33%-5.50%+25.55%+64.08% 443B
+0.68%+0.25%+38.47%+31.95% 349B
-1.66%-1.89%+32.18%+37.17% 297B
-8.96%-9.23%+3.57%+3.64% 264B
-1.37%-5.71%-2.10%-44.43% 209B
-1.63%+0.75%+27.62%+64.43% 208B
+0.72%+1.42%+15.88%+73.30% 162B
Average -1.76%-1.04%+26.38%+42.21% 357.61B
Weighted average by Cap. -1.88%-2.16%+34.56%+69.51%

Financials

2026 *2027 *
Net sales 1.21B 1.39B 1.13B 1.04B 1.95B 133B 1.99B 13.3B 5.21B 66.1B 5.22B 5.11B 218B 1.25B 1.44B 1.17B 1.08B 2.03B 138B 2.06B 13.81B 5.41B 68.61B 5.42B 5.3B 226B
Net income 139M 160M 130M 119M 225M 15.24B 229M 1.53B 599M 7.6B 601M 587M 25.07B 155M 179M 145M 133M 251M 17.02B 255M 1.71B 669M 8.49B 671M 656M 27.99B
Net Debt 792M 911M 740M 679M 1.28B 86.87B 1.3B 8.72B 3.42B 43.32B 3.42B 3.35B 143B 636M 731M 593M 545M 1.03B 69.7B 1.04B 7B 2.74B 34.76B 2.75B 2.69B 115B
Logo Dermapharm Holding SE
Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
Employees
3,503
Date Price Change Volume
03/08/26 41.00 0.00% 11,011
31/07/26 €41.00 -1.91% 26,557
30/07/26 €41.80 -2.45% 19,427
29/07/26 €42.85 +2.63% 14,146
28/07/26 €41.75 +2.45% 23,019
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
41.00EUR
Average target price
50.38EUR
Spread / Average Target
+22.87%

Quarterly revenue - Rate of surprise